Top UK University is First to Install Dyversity 2D Gel Imager

To Help Identify Proteins Associated with Multiple Human Diseases

March 13th 2007 Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is pleased to announce that one of the UK’s premier universities, Imperial College London, has chosen Dyversity, its 2D gel imaging system, to assist in identifying the complex proteins associated with human diseases.

The installation provides Syngene with another high-profile customer in the 2D gel market. In addition to multiplex imaging of 2D protein gels pre-labelled by Cy dyes, the Dyversity system, which has been fitted with precision made filters, UV and visible lighting modules, will be used by up to 200 scientists a year in the Institute of Biomedical Engineering at Imperial College to image 1D protein and DNA gels, as well as chemiluminescent blots stained with a range of visible, fluorescent and chemiluminescent dyes respectively.

Dr Judit Nagy, Research Scientist in Proteomics, Institute of Biomedical Engineering, explained: “When the Institute opened last year, we wanted to make sure that our core facilities would support all scientists in the institute and their multi disciplinary research. This meant that we needed an image acquisition system which could be used in a wide range of research projects to perform the most demanding 2D gel imaging, as well as the simplest gel documentation.”

“Having evaluated four systems from major suppliers, we chose Dyversity because its functionality is equivalent to two imaging systems and a laser scanner, but in one unit. We are delighted to be the first site in the UK to have a Dyversity system,” added Dr Nagy.

Laura Sullivan, Syngene’s Divisional Manager stated: “Imperial College is world-renowned for scientific excellence and cutting edge applied medical research. It is a great compliment to know such astute scientists have chosen a Dyversity system and that it will be used as part of so many important proteomics research programmes."

-Ends-

For Further Information Contact:

Jayne Arthur, Syngene, Beacon House, Nuffield Road, Cambridge, CB4 1TF, UK.
Tel: +44(0) 1223-727123 Fax +44 (0) 1223-727101
Email: jayne.arthur@syngene.com  Web site: www.2dymension.com 

Dr Judit Nagy, Institute of Biomedical Engineering, Imperial College London, Bessemer Building, London, SW7 2AZ, UK.
Tel: +44 (0)20 75943140 Fax: +44 (0)20 7594 0704
Email: j.nagy@imperial.ac.uk  Web site: www.imperial.ac.uk

Editor Contact:
Dr Sue Pearson, PO Box 170, Hitchin, Hertfordshire SG5 3GD, UK.
Tel/Fax +44 (0) 1462-635327 Email: sue6.pearson@ntlworld.com

Note to Editors

About Syngene

Syngene is a world-leading supplier of integrated imaging solutions for analysis and documentation of gel-based information. Syngene’s systems are used by more than 10,000 research organisations and over 50,000 individual scientists world-wide and include many of the world’s top pharmaceutical companies and major research institutes.

Syngene, founded in 1997 is a division of the Cambridge based Synoptics Group. The Group’s other divisions, Syncroscopy and Synbiosis, specialise in digital imaging solutions for microscopy and microbial applications respectively. Synoptics currently employs 60 people in its UK and subsidiary operation in Frederick, USA.

About Imperial College London

Consistently rated in the top three UK university institutions, Imperial College London is a world leading science-based university whose reputation for excellence in teaching and research attracts students (11,500) and staff (6,000) of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and management and delivers practical solutions that enhance the quality of life and the environment - underpinned by a dynamic enterprise culture.